Medikaloka Hermina PT (HEAL) — Cash Flow Reinvestment Rate
Medikaloka Hermina PT (HEAL) has a Cash Flow Reinvestment Rate of 3.96x as of June 2025, reinvesting Rp893.33 Billion (capex Rp442.71 Billion plus investments Rp-450.61 Billion) from operating cash flow of Rp225.37 Billion. See Medikaloka Hermina PT (HEAL) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Medikaloka Hermina PT Cash Flow Reinvestment Rate (2015–2024)
Historical reinvestment intensity for Medikaloka Hermina PT across 10 annual periods. For the full cash flow conversion analysis, see how efficiently does Medikaloka Hermina PT generate cash.
Annual Cash Flow Reinvestment Rate for Medikaloka Hermina PT (2015–2024)
Year-by-year capital reinvestment analysis for Medikaloka Hermina PT. See HEAL FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 4.08x | Rp4.65 Trillion | Rp1.14 Trillion | Rp2.28 Trillion | ▲ +64.8% |
| 2023 | 2.48x | Rp3.27 Trillion | Rp1.32 Trillion | Rp1.59 Trillion | ▲ +10.5% |
| 2022 | 2.24x | Rp1.13 Trillion | Rp503.58 Billion | Rp1.13 Trillion | ▲ +211.9% |
| 2021 | 0.72x | Rp1.33 Trillion | Rp1.86 Trillion | Rp1.21 Trillion | ▼ -19.9% |
| 2020 | 0.90x | Rp1.01 Trillion | Rp1.13 Trillion | Rp889.65 Billion | ▼ -26.3% |
| 2019 | 1.22x | Rp697.10 Billion | Rp572.58 Billion | Rp575.94 Billion | ▼ -66.8% |
| 2018 | 3.66x | Rp885.32 Billion | Rp241.67 Billion | Rp764.16 Billion | ▲ +18.0% |
| 2017 | 3.10x | Rp1.44 Trillion | Rp465.08 Billion | Rp696.31 Billion | ▲ +117.4% |
| 2016 | 1.43x | Rp517.92 Billion | Rp362.85 Billion | Rp487.92 Billion | ▼ -24.4% |
| 2015 | 1.89x | Rp482.66 Billion | Rp255.71 Billion | Rp452.66 Billion | — |